American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease

Abstract

Most recommendations were conditional due to a paucity of direct, high-quality evidence for outcomes of interest. Future research was identified, including the need for prospective studies to better understand the natural history of cardiopulmonary and renal disease, their relationship to patient-important outcomes, and optimal management.